Название продукции:6-chloro-3-iodo-1H-pyrazolo[3,4-b]pyrazine

IUPAC Name:6-chloro-3-iodo-1H-pyrazolo[3,4-b]pyrazine

CAS:1935196-58-9
Молекулярная формула:C5H2ClIN4
Чистота:95%+
Номер в каталоге:CM325847
Молекулярная масса:280.45

Упаковочная единица Доступно для заказа Цена ($) Количество
CM325847-250mg in stock ƱƋ
CM325847-1g in stock ɅŴȷ
CM325847-5g in stock ƙȦȷ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1935196-58-9
Молекулярная формула:C5H2ClIN4
Точка плавления:-
Smiles-код:IC1C2C(=NC(=CN=2)Cl)NN=1
Плотность:
Номер в каталоге:CM325847
Молекулярная масса:280.45
Точка кипения:
Номер Mdl:MFCD26521481
Хранение:Keep in a tight container and store at 2°C~8°C

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.
Pyrazines
Pyrazine is a heterocyclic aromatic organic compound with chemical formula C4H4N2. The marketed pyrazine drugs are mainly distributed in the field of anti-tumor and anti-infection. In recent years, there have been many new drugs in various fields, and there are some new target drugs worthy of attention.
pyrazine,pyrazine price
if you want to know the latest news about pyrazine and pyrazine price, please come to our website and get a quote for free.

Column Infos

GDC-1971
Protein tyrosine phosphatase SHP2 mediates RAS-driven MAPK signaling and has emerged in recent years as a target of interest in oncology, both for treating with a single agent and in combination with a KRAS inhibitor. GDC-1971 (formerly RLY-1971) is a SHP2 inhibitor currently in clinical trials in combination with KRAS G12C inhibitor divarasib (GDC-6036) for the treatment of solid tumors driven by a KRAS G12C mutation.

Related Products